Key result
CCTA-derived percent atheroma volume improves mortality and MI risk discrimination over CAC scoring.
Why the study?
Does AI-driven CCTA-derived quantitative plaque assessment improve prediction of adverse cardiovascular outcomes compared to CAC scoring in patients with suspected CAD?
Cohort (n=2,404)
Does AI-driven CCTA-derived quantitative plaque assessment improve prediction of adverse cardiovascular outcomes compared to CAC scoring in patients with suspected CAD?
Effect estimate: AUC 0.729
p-value: p=0.016
AI-driven assessment of coronary plaque burden via CCTA provides superior prognostic accuracy for future adverse cardiovascular events compared to traditional CAC scoring.
AIMS: To assess the prognostic utility of coronary artery calcium (CAC) scoring and coronary computed tomography angiography (CCTA)-derived quantitative plaque metrics for predicting adverse cardiovascular outcomes. METHODS AND RESULTS: The study enrolled 2404 patients with suspected coronary artery disease (CAD) but without a prior history of CAD. All participants underwent CAC scoring and CCTA, with plaque metrics quantified using an artificial intelligence (AI)-based tool (Cleerly, Inc). Percent atheroma volume (PAV) and non-calcified plaque volume percentage (NCPV%), reflecting total plaque burden and the proportion of non-calcified plaque volume normalized to vessel volume, were evaluated. The primary endpoint was a composite of all-cause mortality and non-fatal myocardial infarction (MI). Cox proportional hazard models, adjusted for clinical risk factors and early revascularization, were employed for analysis. During a median follow-up of 7.0 years, 208 patients (8.7%) experienced the primary endpoint, including 73 cases of MI (3%). The model incorporating PAV demonstrated superior discriminatory power for the composite endpoint (AUC = 0.729) compared to CAC scoring (AUC = 0.706, P = 0.016). In MI prediction, PAV (AUC = 0.791) significantly outperformed CAC (AUC = 0.699, P < 0.001), with NCPV% showing the highest prognostic accuracy (AUC = 0.814, P < 0.001). CONCLUSION: AI-driven assessment of coronary plaque burden enhances prognostic accuracy for future adverse cardiovascular events, highlighting the critical role of comprehensive plaque characterization in refining risk stratification strategies.
No takes yet. Share an insight, caveat, or question.
Dahdal et al. (2025) conducted a cohort in suspected coronary artery disease (CAD) (n=2,404). CCTA-derived quantitative plaque metrics (PAV and NCPV%) vs. Coronary artery calcium (CAC) scoring was evaluated on composite of all-cause mortality and non-fatal myocardial infarction (MI) (AUC 0.729, p=0.016). CCTA-derived percent atheroma volume demonstrated superior discriminatory power for all-cause mortality and non-fatal MI compared to CAC scoring (AUC 0.729 vs 0.706, P=0.016).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: